Submissions from 2021
MUTYH as an Emerging Predictive Biomarker in Ovarian Cancer, Megan L. Hutchcraft, Holly H. Gallion, and Jill M. Kolesar
Mithramycin and Analogs for Overcoming Cisplatin Resistance in Ovarian Cancer, David Schweer, J. Robert McCorkle, Jurgen Rohr, Oleg V. Tsodikov, Frederick R. Ueland, and Jill M. Kolesar
Submissions from 2020
CCNE1 Amplification as a Predictive Biomarker of Chemotherapy Resistance in Epithelial Ovarian Cancer, Justin W. Gorski, Frederick R. Ueland, and Jill M. Kolesar
Concurrent Hysterectomy and Bilateral Salpingo-Oophorectomy during Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Non-Gynecologic Cancers, McKayla J. Riggs, Miranda Lin, Joseph Kim, Prakash Pandalai, and Charles S. Dietrich III
DACH1 Mutation Frequency in Endometrial Cancer Is Associated with High Tumor Mutation Burden, McKayla J. Riggs, Nan Lin, Chi Wang, Dava W. Piecoro, Rachel W. Miller, Oliver A. Hampton, Mahadev Rao, Frederick R. Ueland, and Jill M. Kolesar
Extreme Elevations of Alkaline Phosphatase in Pregnancy: A Case Report, Zachary Stanley, Katherine Vignes, and Miriam Marcum
Submissions from 2019
Disparities in Quality of Life by Appalachian-Designation among Women with Breast Cancer, Robin C. Vanderpool, Ann L. Coker, Heather M. Bush, and Sarah E. Cprek
Submissions from 2018
Comparison of Serum and Cervical Cytokine Levels Throughout Pregnancy Between Preterm and Term Births, Kristin Ashford, Niraj R. Chavan, Amanda T. Wiggins, Molly Malany Sayre, Andrea McCubbin, Agatha S. Critchfield, and John O'Brien
Associations of Demographic Factors and Tobacco Use With Progesterone and Estradiol During Pregnancy, Kristin Ashford, Emily Rayens, Amanda T. Wiggins, Mary Kay Rayens, Molly Malany Sayre, and John O'Brien
Endometrial Response to Conceptus-Derived Estrogen and Interleukin-1β at the Time of Implantation in Pigs, Hakhyun Ka, Heewon Seo, Yohan Choi, Inkyu Yoo, and Jisoo Han
Membrane Associated Collagen XIII Promotes Cancer Metastasis and Enhances Anoikis Resistance, Hui Zhang, Tricia Fredericks, Gaofeng Xiong, Yifei Qi, Piotr G. Rychahou, Jia-Da Li, Taina Pihlajaniemi, Wei Xu, and Ren Xu
Submissions from 2017
Ovarian Cancer Incidence Corrected for Oophorectomy, Lauren A. Baldwin, Quan Chen, Thomas C. Tucker, Connie G. White, Robert N. Ore, and Bin Huang
Complications from Surgeries Related to Ovarian Cancer Screening, Lauren A. Baldwin, Edward J. Pavlik, Emma Ueland, Hannah E. Brown, Kelsey M. Ladd, Bin Huang, Christopher P. DeSimone, John R. Van Nagell, Frederick R. Ueland, and Rachel W. Miller
Granulosa Cell Endothelin-2 Expression is Fundamental for Ovulatory Follicle Rupture, Joseph A. Cacioppo, Po-Ching Patrick Lin, Patrick R. Hannon, Daniel R. McDougle, Arnon Gal, and CheMyong Ko
Buprenorphine for Medication-Assisted Treatment of Opioid Use Disorder in Pregnancy: Relationship to Neonatal Opioid Withdrawal Syndrome, Niraj R. Chavan, Kristin Ashford, Amanda T. Wiggins, Michelle R. Lofwall, and Agatha S. Critchfield
RCT Testing Bystander Effectiveness to Reduce Violence, Ann L. Coker, Heather M. Bush, Patricia G. Cook-Craig, Sarah A. DeGue, Emily R. Clear, Candace J. Brancato, Bonnie S. Fisher, and Eileen A. Recktenwald
Intimate Partner Violence and Women's Cancer Quality of Life, Ann L. Coker, Diane R. Follingstad, Lisandra S. Garcia, and Heather M. Bush
Symptoms Relevant to Surveillance for Ovarian Cancer, Robert M. Ore, Lauren Baldwin, Dylan Woolum, Erika Elliott, Christiaan Wijers, Chieh-Yu Chen, Rachel W. Miller, Christopher P. DeSimone, Frederick R. Ueland, Richard J. Kryscio, John R. Van Nagell, and Edward J. Pavlik
Ultrasound Monitoring of Extant Adnexal Masses in the Era of Type 1 and Type 2 Ovarian Cancers: Lessons Learned From Ovarian Cancer Screening Trials, Eleanor L. Ormsby, Edward J. Pavlik, and John P. McGahan
Ovarian Cancer Screening: Lessons About Effectiveness, Edward J. Pavlik
Ten Important Considerations for Ovarian Cancer Screening, Edward J. Pavlik
Increased Birth Weight is Associated with Altered Gene Expression in Neonatal Foreskin, Leryn J. Reynolds, Rebecca I. Pollack, Richard J. Charnigo, Cetewayo S. Rashid, Arnold J. Stromberg, Shu Shen, John O'Brien, and Kevin J. Pearson
A Perspective on Ovarian Cancer Biomarkers: Past, Present and Yet-To-Come, Frederick R. Ueland
Inhibition of the Integrin/FAK Signaling Axis and c-Myc Synergistically Disrupts Ovarian Cancer Malignancy, B. Xu, Jason R. Lefringhouse, Z. Liu, D. West, Lauren A. Baldwin, C. Ou, L. Chen, Dana L. Napier, Luksana Chaiswing, Lawrence D. Brewer, Daret K. St Clair, Olivier Thibault, John R. van Nagell, Binhua P. Zhou, R. Drapkin, J.-A. Huang, M. L. Lu, Frederick R. Ueland, and X. H. Yang
Submissions from 2016
Partner Interfering Behaviors Affecting Cancer Quality of Life, Ann L. Coker, Diane R. Follingstad, Lisandra S. Garcia, and Heather M. Bush